PCSK1 and Alzheimer disease: Emerging evidence indicates that Nec‐1 displays a neuroprotective effect in reversing the clinical hallmarks and symptoms in a murine AD model.7, 8, 9, 10 However, these beneficial outcomes have yet to be elucidated on a human AD model.